Sanofi
SNY
710 hedge funds and large institutions have $11.2B invested in Sanofi in 2025 Q3 according to their latest regulatory filings, with 71 funds opening new positions, 255 increasing their positions, 262 reducing their positions, and 81 closing their positions.
75% more funds holding in top 10
Funds holding in top 10: 4 → 7 (+3)
0.28% less ownership
Funds ownership: 9.97% → 9.68% (-0.28%)
3% less repeat investments, than reductions
Existing positions increased: 255 | Existing positions reduced: 262
9% less call options, than puts
Call options by funds: $125M | Put options by funds: $138M
3% less funds holding
Funds holding: 729 → 710 (-19)
5% less capital invested
Capital invested by funds: $11.8B → $11.2B (-$601M)
12% less first-time investments, than exits
New positions opened: 71 | Existing positions closed: 81
Top Buyers
| 1 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
+$105M |
| 2 |
Millennium Management
New York
|
+$63.7M |
| 3 |
BNP Paribas Financial Markets
Paris,
France
|
+$41.5M |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
+$39M |
| 5 |
Barclays
London,
United Kingdom
|
+$38.6M |
Top Sellers
| 1 |
Capital World Investors
Los Angeles,
California
|
-$404M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$164M |
| 3 |
Dodge & Cox
San Francisco,
California
|
-$134M |
| 4 |
Raymond James Financial
St Petersburg,
Florida
|
-$118M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$41.1M |
SNY Hedge Fund Activity: Q3 2025 in Review
710 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in Sanofi (SNY) for Q3 2025, worth a combined $11.2B — down 5.1% from $11.8B a quarter earlier.
Sellers outnumbered buyers: 81 funds closed out of SNY and 71 opened new positions — a net loss of 10 holders — while 262 trimmed existing stakes and 255 added.
The largest buyer was Thrivent Financial for Lutherans, adding an estimated $105M. The largest seller was Capital World Investors, exiting entirely with an estimated $404M sold.
- 710 institutional investors held Sanofi (SNY) as of Q3 2025, down from 729 in Q2 2025.
- Funds reported $11.2B of Sanofi stock for Q3 2025, down 5.1% quarter-over-quarter.
- 71 funds opened new Sanofi positions in Q3 2025 and 81 closed out, a net change of -10 holders.
- The largest Sanofi buyer in Q3 2025 was Thrivent Financial for Lutherans, an estimated $105M added.
- The largest Sanofi seller in Q3 2025 was Capital World Investors, an estimated $404M sold.
Based on aggregated 13F filings for Q3 2025.